Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Editorial

Published on 26 Jan 2023

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II

in Pharmacology of Infectious Diseases

Jaime Ribeiro-Filho
Yanna Carolina Ferreira Teles
John Ogbaji Igoli
Raffaele Capasso

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144074

1,769 views
1 citation

Mini Review

Published on 24 Jan 2023

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens

in Pharmacology of Infectious Diseases

Bikash Baral

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1036051

8,182 views
13 citations

Original Research

Published on 17 Jan 2023

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

in Pharmacology of Infectious Diseases

Maryam Hajimoradi
Babak Sharif Kashani
Farzaneh Dastan
Sina Aghdasi
Atefeh Abedini
Farah Naghashzadeh
Arezoo Mohamadifar
Mohammad Sadegh Keshmiri
Sima Noorali
Somayeh Lookzadeh

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1107198

4,048 views
6 citations

Original Research

Published on 13 Jan 2023

Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study

in Pharmacology of Infectious Diseases

Xinge Cui
Xin Zheng
Jianwei Ren
Hongzhong Liu
Yuan Jia
Aiguo Wu
Xiaohong Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076046

2,372 views
4 citations

Systematic Review

Published on 09 Jan 2023

Activity of the genus Zanthoxylum against diseases caused by protozoa: A systematic review

in Pharmacology of Infectious Diseases

Juliana Correa-Barbosa
Daniele Ferreira Sodré
Pedro Henrique Costa Nascimento
Maria Fâni Dolabela

Frontiers in Pharmacology

doi 10.3389/fphar.2022.873208

2,909 views
5 citations

Original Research

Published on 09 Jan 2023

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis

in Pharmacology of Infectious Diseases

Haoyue Zhang
Yuying He
Lina Davies Forsman
Jakob Paues
Jim Werngren
Katarina Niward
Thomas Schön
Judith Bruchfeld
Jan-Willem Alffenaar
Yi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1032674

4,179 views
9 citations

Opinion

Published on 05 Jan 2023

How and when does monkeypox (mpox) transmit: Implications for prevention and treatments

in Pharmacology of Infectious Diseases

Shu Yuan
Si-Cong Jiang
Zhong-Wei Zhang
Yu-Fan Fu
Xin-Yue Yang
Zi-Lin Li
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1109928

3,370 views
5 citations

Original Research

Published on 04 Jan 2023

Successful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country

in Pharmacology of Infectious Diseases

Faouzi I. Maalouf
Therese Saad
Ramia Zakhour
Khalid Yunis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1076392

2,374 views
7 citations

Original Research

Published on 04 Jan 2023

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

in Pharmacology of Infectious Diseases

Juan Eduardo Resendiz-Galvan
Prerna R. Arora
Mahmoud Tareq Abdelwahab
Zarir F. Udwadia
Camilla Rodrigues
Amita Gupta
Paolo Denti
Tester F. Ashavaid
Jeffrey A. Tornheim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081123

4,116 views
5 citations

Original Research

Published on 20 Dec 2022

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters

in Pharmacology of Infectious Diseases

Rana Abdelnabi
Piet Maes
Steven de Jonghe
Birgit Weynand
Johan Neyts

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1072202

5,066 views
19 citations

Original Research

Published on 16 Dec 2022

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae

in Pharmacology of Infectious Diseases

Zhenwei Yu
Xiaofen Liu
Xiaoxing Du
Huiying Chen
Feng Zhao
Zhihui Zhou
Yu Wang
Yang Zheng
Phillip J. Bergen
Xi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.975066

5,793 views
18 citations

Original Research

Published on 13 Dec 2022

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells

in Pharmacology of Infectious Diseases

Giada Lodi
Valentina Gentili
Fabio Casciano
Arianna Romani
Giorgio Zauli
Paola Secchiero
Enrico Zauli
Carolina Simioni
Silvia Beltrami
Mercedes Fernandez

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1018761

3,691 views
10 citations

Clinical Trial

Published on 12 Dec 2022

A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19

in Pharmacology of Infectious Diseases

Yan Liu
Guanxing Zhai
Weihui Fu
Xiaoyan Zhang
Jianqing Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063106

1,852 views
1 citation

Original Research

Published on 12 Dec 2022

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis

in Pharmacology of Infectious Diseases

Nicole F. Maranchick
Mohammad H. Alshaer
Alison G. C. Smith
Teona Avaliani
Mariam Gujabidze
Tinatin Bakuradze
Shorena Sabanadze
Zaza Avaliani
Maia Kipiani
Charles A. Peloquin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1048653

6,483 views
15 citations

Review

Published on 09 Dec 2022

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

in Pharmacology of Infectious Diseases

Jan-Willem C. Alffenaar
Jurriaan E. M. de Steenwinkel
Andreas H. Diacon
Ulrika S. H. Simonsson
Shashikant Srivastava
Sebastian G. Wicha

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063453

10,772 views
21 citations

Original Research

Published on 01 Dec 2022

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis

in Pharmacology of Infectious Diseases

Yun He
Chenchen Wang
Qi Liang
Rongjie Guo
Jiaxuan Jiang
Wenhao Shen
Kai Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1048978

4,673 views
11 citations